肿瘤药学2016，Vol.6Issue(5)：326-332,7.DOI:10.3969/j.issn.2095-1264.2016.05.02
宫颈腺癌的诊治及研究进展
Research Progress of the Diagnosis and Treatment of Cervical Adenocarcinoma
摘要
Abstract
Cervical adenocarcinoma (CA), the secondary type to squamouscarcinoma(SCC), accounts for 20%of all cervical cancer. Recently, there is a rising incidence and proportion of CA related to cervical cancer. CA is more often seen in younger population and has a poorer prognosis than SCC. In addition, compared with SCC, it is hard to screen early, and has high rate of ovarian metastasis and low sensi-tivity to both radiotherapy and chemotherapy;all affect the diagnosis and treatment of CA. In this article, we reviewed the research progress of diagnosis and treatment of cervical adenocarcinoma, focusing on etiology(human papillomavirus and gene mutation), screening(molecular biomarker), treatment(surgery, radiotherapy and chemotherapy, ovarian preservation, and fertility-sparing)and prognostic marker.关键词
宫颈腺癌/早期筛查/治疗/预后标记物/研究进展Key words
Cervical Adenocarcinoma/Screenearly/Treatment/Prognostic Marker/Research Progress分类
医药卫生引用本文复制引用
陈嫣,王静,王子毅,许一诺,洪婷..宫颈腺癌的诊治及研究进展[J].肿瘤药学,2016,6(5):326-332,7.基金项目
湖南省卫生计生委重点课题（A2015-3）。 （）
